Vera Therapeutics is trading at $35.20, up +4.76% on September 11, 2026, alongside broad market gains after August inflation data matched expectations.

  • The S&P 500, Nasdaq, and Dow were each up more than 0.5%, supporting a global risk-on explanation.
  • Vera’s September 10 healthcare-conference update highlighted solid TRUTAKNA launch traction but did not explicitly link it to the share move.